Home
Heidi Espedal's picture

Heidi Espedal

Postdoctoral fellow, + manager of preclinical PET/CT (MIC)
  • E-mailHeidi.Espedal@uib.no
  • Phone+47 55 97 76 17
  • Visitor Address
    Parkbygget, Haukeland Universitetssykehus
    Room 
    7913, 0-floor
  • Postal Address
    Postboks 7804
    5020 Bergen
  • Gras Navarro, Andrea; Espedal, Heidi; Vareecal Joseph, Justin; Moncho, Laura Trachsel; Bahador, Marzieh; Gjertsen, Bjørn Tore; Kristoffersen, Einar Klæboe; Simonsen, Anne; Miletic, Hrvoje; Enger, Per Øyvind; Rahman, Mohummad Aminur; Enger, Martha Chekenya. 2019. Pretreatment of glioblastoma with bortezomib potentiates natural killer cell cytotoxicity through TRAIL/DR5 mediated apoptosis and prolongs animal survival. Cancers. 1-25.
  • Aasen, Synnøve Nymark; Espedal, Heidi; Holte, Christopher Florian; Keunen, Olivier; Karlsen, Tine Veronica; Tenstad, Olav; Maherally, Zaynah; Miletic, Hrvoje; Hoang, Tuyen; Eikeland, Anne Vaag; Baghirov, Habib; Olberg, Dag Erlend; Pilkington, Geoffrey John; Sarkar, Gobinda; Jenkins, Robert B.; Sundstrøm, Terje; Bjerkvig, Rolf; Thorsen, Frits. 2019. Improved drug delivery to brain metastases by peptide-mediated permeabilization of the blood-brain barrier. Molecular Cancer Therapeutics. 2171-2181.
  • Espedal, Heidi; Fonnes, Tina; Fasmer, Kristine Eldevik; Krakstad, Camilla; Haldorsen, Ingfrid S. 2019. Imaging of preclinical endometrial cancer models for monitoring tumor progression and response to targeted therapy. 1-16.
  • Obad, Nina; Espedal, Heidi; Jirík, Radovan; Sakariassen, Per Øystein; Rygh, Cecilie Brekke; Lund-Johansen, Morten; Taxt, Torfinn; Niclou, Simone Pierrette; Bjerkvig, Rolf; Keunen, Olivier. 2017. Lack of functional normalisation of blood vessels following anti-angiogenic therapy in glioblastoma. Journal of Cerebral Blood Flow and Metabolism. 1741-1753.
  • Podergajs, Neza; Motaln, H; Rajcevic, Uros; Verbovsek, U; Korsic, M; Obad, Nina; Espedal, Heidi; Vittori, M; Herold-Mende, Christel; Miletic, Hrvoje; Bjerkvig, Rolf; Turnsek, TL. 2016. Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells. OncoTarget.
  • Brattekås, Bergit; Steinsbø, Marianne; Graue, Arne; Fernø, Martin; Espedal, Heidi; Seright, Randall S. 2016. New insight into wormhole formation in polymer gel during water chase floods with positron emission tomography. SPE Journal. 32-40.
  • Brattekås, Bergit; Steinsbø, Marianne; Graue, Arne; Fernø, Martin; Espedal, Heidi; Seright, Randall S. 2016. New Insight to Wormhole Formation in Polymer Gel during Water Chasefloods using Positron Emission Tomography (PET).
  • Sundstrøm, Terje; Espedal, Heidi; Harter, Patrick N.; Fasmer, Kristine Eldevik; Skaftnesmo, Kai Ove; Horn, Sindre August; Hodneland, Erlend; Mittelbronn, Michel; Weide, Benjamin; Beschorner, Rudi; Bender, Benjamin; Rygh, Cecilie Brekke; Lund-Johansen, Morten; Bjerkvig, Rolf; Thorsen, Frits. 2015. Melanoma brain metastasis is independent of lactate dehydrogenase A expression. Neuro-Oncology. 1374-1385.
  • Burtey, Anne Pierrette; Wagner, Marek; Hodneland, Erlend; Skaftnesmo, Kai Ove; Schölermann, Julia; Rios Mondragon, Ivan; Espedal, Heidi; Golebiewska, Anna; Niclou, Simone; Bjerkvig, Rolf; Kögel, Tanja; Gerdes, Hans-Hermann. 2015. Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes. The FASEB Journal. 4695-4712.
  • Espedal, Heidi. 2015. Glycolysis in malignant brain tumors. Therapeutic implications for glioblastoma and melanoma brain metastasis.
  • Huszthy, Peter Csaba; Sakariassen, Per Øystein; Espedal, Heidi; Brokstad, Karl Albert; Bjerkvig, Rolf; Miletic, Hrvoje. 2015. Engraftment of human glioblastoma cells in immunocompetent rats through acquired immunosuppression. PLOS ONE.
  • Fack, Fred; Espedal, Heidi; Keunen, Olivier; Golebiewska, Anna; Obad, Nina; Harter, Patrick N.; Mittelbronn, Michel; Bähr, Oliver; Weyerbrock, Astrid; Stuhr, Linda Elin Birkhaug; Miletic, Hrvoje; Sakariassen, Per Øystein; Stieber, Daniel; Brekke, Cecilie; Lund-Johansen, Morten; Zheng, Liang; Gottlieb, Eyal; Niclou, Simone; Bjerkvig, Rolf. 2015. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathologica. 115-131.
  • Pakzad, Ashraf Fathpour; Obad, Nina; Espedal, Heidi; Stieber, Daniel; Keunen, Olivier; Sakariassen, Per Øystein; Niclou, Simone; Bjerkvig, Rolf. 2014. Bevacizumab treatment for human glioblastoma. Can it induce cognitive impairment? Neuro-Oncology. 754-759.
  • Fack, F; Espedal, Heidi; Obad, Nina; Keunen, Olivier; Gotlieb, E; Sakariassen, Per Øystein; Miletic, Hrvoje; Niclou, Simone P; Bjerkvig, Rolf. 2013. GLIOBLASTOMA ADAPTATION TO ANTI-VASCULAR THERAPY INVOLVES AN UP-REGULATION OF GLYCOLYSIS WHERE LACTATE DEHYDROGENASE (LDH) REPRESENTS A POTENTIAL THERAPEUTIC TARGET. Neuro-Oncology. 7-7.
  • Abdalla, Hisham Saghayroon E. 2012. Characterization of Lactate Dehydrogenase Expression in distinct Glioma Phenotypes.
  • Espedal, Heidi. 2010. The Expression and Localization of Id1 and Id3 in Glioblastoma Multiforme.
  • Espedal, Heidi; Johannessen, Ola M; Knulst, J. 1996. Satellite detection of natural films on the ocean surface. Geophysical Research Letters. 3151-3154.

More information in national current research information system (CRIStin)